Ardelyx reported $504.51M in Assets for its fiscal quarter ending in March of 2026.





Assets Change Date
Abbott USD 110.43B 23.72B Mar/2026
Amgen USD 92.5B 1.92B Mar/2026
Ardelyx USD 504.51M 2.9M Mar/2026
aTyr Pharma USD 79.65M 435.68M Mar/2026
Corcept Therapeutics USD 814.88M 21.77M Mar/2026
Curis USD 19.97M 9.27M Dec/2025
Sanofi EUR 126.81B 25.48B Dec/2025
TG Therapeutics USD 1.53B 465.58M Mar/2026
United Therapeutics USD 6.71B 1.17B Mar/2026
Xoma USD 263.15M 39.7M Sep/2025